## BACKGROUND. Chromosomal abnormalities in some lymphomas are associated with a poor prognosis. Trisomy 12 and deletions of chromosome 13 have been described in small lymphocytic lymphoma (SLL). To determine whether chromosomal aberrations could be detected by fluorescence in situ hybridization (F
Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors
β Scribed by Tsukamoto, Fumine ;Miyoshi, Yasuo ;Koyama, Hiroki ;Watatani, Masahiro ;Sasa, Mitsunori ;Shiba, Eiichi ;Takami, Satoshi ;Inazawa, Johji ;Noguchi, Shinzaburo
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 153 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The chromosomal organization of amplified chromosome 12 sequences was studied with fluorescence in situ hybridization in six mesenchymal tumors: two osteosarcomas, one lipoma, two liposarcomas, and one fibrosarcoma. All except the fibrosarcoma contained ring and/or giant marker chromosomes. Amplific
TP53 mutations have been found in 16-64% of breast carcinomas. The aim of our study was to investigate loss of the wild-type TP53 gene by in situ hybridization (ISH) of fine-needle aspirates (FNAC) from breast carcinomas. The material consisted of FNAC from 33 breast carcinomas, with histologic spec
Interphase cytogenetics by fluorescence in situ hybridization (FISH) can be used to detect malignant cells characterized by chromosomal aneuploidy. However, apparent aneusomy in normal ''control'' tissues has to be considered when using FISH as diagnostic tool. In effusions as model tissue exposed t
The estrogen receptor (ER) gene is located on chromosome 6. The aim of our study was to investigate whether numerical chromosomal aberrations were reflected in estrogen/progesterone receptor (PgR) status and staining pattern. Fine-needle aspirates from 51 breast carcinomas were investigated immunocy
## BACKGROUND. Fine-needle sampling, although a practical and noninvasive method of tissue acquisition, has rarely been used for HER-2/neu fluorescent in situ hybridization (FISH). To assess HER-2/neu gene amplification in mammary carcinoma, FISH signals on cytology and corresponding tissue biopsie